Fabio
8.8 KiB
8.8 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment. | Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment. | us/states/tx | Texas Legislature | 89R | SB 2308 | Texas SB 2308 (89R) |
|
|
enacted |
|
5 | 73 | 7 | 2025-03-11 | 2025-06-11 | openstates | ocd-bill/030f9ad6-df65-4b98-9917-1146e6ad7923 | ftp://ftp.legis.state.tx.us/bills/89R/billhistory/senate_bills/SB02300_SB02399/SB 2308.xml | 7c2cb79b388b4547ac7d8b675f98f1e3de5d840ac445347b94fc71a22ac3386a | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Texas SB 2308 (89R) — Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Introduced (filed) — source
- Engrossed (committee substitute) — source
- House Committee Report (committee substitute) — source
- Senate Committee Report (committee substitute) — source
- Enrolled (enrolled) — source
Votes
- passage — 26–5 (pass) · upper
- passage — 134–4 (pass) · lower
- passage — 138–2 (pass) · lower
- passage — 134–4 (pass) · upper
- passage — 141–2 (pass) · lower
- Senate Rule 7.18 and the Constitutional Rule requiring bills to be read on three several days be suspended and that SB 2308 be placed on its third reading and final passage. — 26–5 (pass) · upper
- passage — 27–4 (pass) · upper
Sponsors
- Harris — primary (person)
- Leach — primary (person)
- Orr — primary (person)
- Parker — primary (person)
- Phelan — primary (person)
- VanDeaver — primary (person)
- Alders — cosponsor (person)
- Barry — cosponsor (person)
- Bell, Keith — cosponsor (person)
- Blanco — cosponsor (person)
- Buckley — cosponsor (person)
- Cain — cosponsor (person)
- Davis, Aicha — cosponsor (person)
- Eckhardt — cosponsor (person)
- Gerdes — cosponsor (person)
- Gámez — cosponsor (person)
- Hefner — cosponsor (person)
- LaHood — cosponsor (person)
- Lalani — cosponsor (person)
- Leo Wilson — cosponsor (person)
- Lopez, Janie — cosponsor (person)
- Lujan — cosponsor (person)
- McLaughlin — cosponsor (person)
- Metcalf — cosponsor (person)
- Miles — cosponsor (person)
- Morales, Eddie — cosponsor (person)
- Olcott — cosponsor (person)
- Pierson — cosponsor (person)
- Raymond — cosponsor (person)
- Schoolcraft — cosponsor (person)
- Shofner — cosponsor (person)
- Swanson — cosponsor (person)
- Tinderholt — cosponsor (person)
- Vasut — cosponsor (person)
- Villalobos — cosponsor (person)
- Zwiener — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2025-03-11 Received by the Secretary of the Senate
filing, introduction - 2025-03-11 Filed
filing - 2025-03-25 Read first time
introduction, reading-1 - 2025-03-25 Referred to Health & Human Services
referral-committee - 2025-04-23 Scheduled for public hearing on . . .
- 2025-04-23 Considered in public hearing
- 2025-04-23 Testimony taken in committee
- 2025-04-23 Left pending in committee
- 2025-04-24 Considered in public hearing
- 2025-04-24 Vote taken in committee
- 2025-04-28 Reported favorably w/o amendments
committee-passage-favorable - 2025-04-28 Committee report printed and distributed
- 2025-04-29 Co-author authorized
- 2025-04-29 Placed on intent calendar
- 2025-04-30 Rules suspended-Regular order of business
- 2025-04-30 Record vote
- 2025-04-30 Read 2nd time & passed to engrossment
reading-2 - 2025-04-30 Record vote
- 2025-04-30 Three day rule suspended
- 2025-04-30 Record vote
- 2025-04-30 Read 3rd time
reading-3 - 2025-04-30 Passed
passage - 2025-04-30 Record vote
- 2025-04-30 Reported engrossed
- 2025-05-01 Received from the Senate
introduction - 2025-05-02 Read first time
introduction, reading-1 - 2025-05-02 Referred to Public Health
referral-committee - 2025-05-08 Considered in formal meeting
- 2025-05-08 Committee substitute considered in committee
substitution - 2025-05-08 Reported favorably as substituted
committee-passage-favorable - 2025-05-12 Comte report filed with Committee Coordinator
filing - 2025-05-12 Committee report distributed
- 2025-05-12 Committee report sent to Calendars
- 2025-05-12 Laid out in lieu of companion
- 2025-05-12 Read 2nd time
reading-2 - 2025-05-12 Amended
amendment-passage - 2025-05-12 Passed to 3rd reading as amended
amendment-passage - 2025-05-12 Record vote
- 2025-05-12 Statement(s) of vote recorded in Journal
- 2025-05-13 Read 3rd time
reading-3 - 2025-05-13 Passed
passage - 2025-05-13 Record vote
- 2025-05-13 Statement(s) of vote recorded in Journal
- 2025-05-14 House passage as amended reported
amendment-passage - 2025-05-15 House amendment(s) laid before the Senate
- 2025-05-15 Read
- 2025-05-15 Senate refuses to concur
- 2025-05-15 Senate requests conference committee
- 2025-05-15 Senate appoints conferees
- 2025-05-15 Senate refuses to concur-reported
- 2025-05-15 Senate requests conference committee-reported
- 2025-05-15 Senate appoints conferees-reported
- 2025-05-20 House grants request for conference committee
- 2025-05-20 House appoints conferees
- 2025-05-21 House grants request for conf comm-reported
- 2025-05-21 House appoints conferees-reported
- 2025-05-30 Conference committee report filed
filing - 2025-05-30 Conf. Comm. Report distributed
- 2025-05-31 Senate adopts resolution to go outside bounds
- 2025-05-31 Senate adopts conference committee report
committee-passage-favorable - 2025-05-31 Record vote
- 2025-05-31 Senate adopts conf. comm. report-reported
- 2025-06-01 House adopts resolution to go outside bounds
- 2025-06-01 House adopts conference committee report
committee-passage-favorable - 2025-06-01 Record vote
- 2025-06-01 Statement(s) of vote recorded in Journal
- 2025-06-01 House adopts conf. comm. report-reported
- 2025-06-02 Reported enrolled
enrolled - 2025-06-02 Signed in the Senate
passage - 2025-06-02 Signed in the House
passage - 2025-06-03 Sent to the Governor
executive-receipt - 2025-06-11 Signed by the Governor
executive-signature - 2025-06-11 Effective immediately
became-law
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/030f9ad6-df65-4b98-9917-1146e6ad7923. Confidence: reported (aggregated from official Texas legislature records).